2024 annual financial data
Dianthus Therapeutics 2024 Operating margin
Dianthus Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -1,633.74%.
Operating income was -101,864,000 USD and net income was -84,969,000 USD.
Operating cash flow was -78,180,000 USD.
Get free Dianthus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,235,000 USD
- Operating income
- -101,864,000 USD
- Net income
- -84,969,000 USD
- Operating cash flow
- -78,180,000 USD